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Weimiao Li†, Lijun Huang†, Yong Han†, Yongan Zhou, Qiang Lu* and Xiaofei Li*Abstract
Radiofrequency ablation (RFA) is an alternative method to treat the inoperable NSCLC and there were few serious
complications after RFA therapy have been reported. Here, we reported a NSCLC patient endured empyema after
treatment by RFA for one month. There was a 20 × 25 × 20 mm mass on the right middle lobe by CT scan before
RFA and a huge gas cavity with liquid was found in the right chest cavity after RFA treatment for twenty- eight
days. A hole in the right middle lobe was found with large amount of pus in the pleural cavity as well as the
bronchopleural fistula (BPF) during the operation. Results from the postoperative pathology showed a multiple
small foci differentiated adenocarcinoma, partial bronchiolar-alveolar carcinoma, 0.5 cm away around the hole at
the same time. It is difficult to diagnose and treat the rare complication of BPF, while, the larger field of ablation
might be helpful to postpone the tumor local progression. Therefore, surgery was a good option for BPF especially
when an empyema occurred.
Virtual slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.eu/
vs/8028049341122276.
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Despite surgical resection was the standard treatment of
localized non–small cell lung cancer (NSCLC), only 20%
of all diagnosed lung cancers were suitable for poten-
tially curative resection [1]. Radiofrequency ablation (RFA)
was proved safe and effective for the treatment of inope-
rable NSCLC as an alternative method [2]. Few serious
complications from RFA have been reported [3]. We re-
ported a NSCLC patient who was first treatment by RFA
and endured empyema one month after treatment.Case presentation
A 60 year-old woman was admitted to our hospital with
complaints of chest pain for over 1 month, with chest
tightness, shortness of breath for 7 days, without fever,
cough, diarrhea and abdominal pain. On admission, a
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stated.as an amount of pleural effusion were showed by a chest
computer tomography (CT) scan (Figure 1A). However,
Bronchoscope was normal. The puncture biopsies con-
firmed adenocarcinoma cells about the lung mass. Tumor
cells were not founded in the pleural effusion with the
puncture examination.
Patient refused surgery and radiofrequency ablation
was performed then. The patient recovered rapidly and
discharged 5 days after RFA treatment. The patient was
readmitted because of chest tightness, shortness of breath
and fever at 38.5°C twenty-three days after discharge.
The number of her leukocytes in blood increased to
22 × 109/L. An emergent chest computer tomography
(CT) scan showed a huge gas cavity and liquid located in
the up right chest cavity (Figure 1B). Empyema was con-
firmed by thoracentesis and thoracotomy was carried out
thereafter. During the operation, we found a hole in the
right middle lobe with large amount of pus in the pleural
cavity (Figure 2). The resected right middle lobe showed a
30 × 35 × 32 mm hole perforating into lobe and communi-
cating with bronchus. The bronchopleural fistula (BPF)his is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Figure 1 Chest CT scans of preoperative and postoperative. A: A chest CT scan showed a 20 × 25 × 20 mm mass on the right middle lobe as
well as an amount of pleural effusion on admission. B: An emergent chest CT scan showed a huge gas cavity and liquid located in the up right
chest cavity.
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thickened (Figure 2). The postoperative pathology con-
firmed the multiple small foci differentiated adenocarci-
noma and partial bronchiolar - alveolar carcinoma at the
edge of hole (Figures 3,4). The postoperative evolution
was uneventful and patient was discharged in 7th days
after operation.
Discussion
In recent years, the treatment of NSCLC is still not
satisfying in spite of the rapid development of lung can-
cer research [4,5]. In addition to the use of chemothe-
rapy drugs [6], RFA is a potential local therapy used for
NSCLC patients who were not suitable for surgery or re-
fused operation [7,8]. Several authors have assessed the
performance of RFA in treatment for primary NSCLC
and the complications of RFA were believed to be accep-
table [9-11]. Our previous studies found that complica-
tions of RFA included pneumothorax (19.1%), hemoptysis
(4.2%), hemothorax (3.0%), pneumonia (4.5%) and peri-
cardial tamponade (0.9%), while absent of empyema. TheFigure 2 A hole in the right middle lobe was found with large
amount of pus in the pleural cavity during the operation.most common complication for the lung RFA was pneu-
mothorax. The bronchopleural fistula (BPF) was an ex-
tremely rare complication [12].
BPF was a serious complication and difficult for the
treatment. Sakurai [13] and Kodama [14] performed bron-
chial occlusion using silicone filler and pleurodesis in
three patients with a BPF. Abu-Hijleh and Blundin [15]
resolved the complication through chest tube drainage.
Lois M et al. [16] healed the air leaks through a chest tube
to produce a pleural symphysis for management of persist-
ent air leaks. In this report, thoracotomy was given with
satisfied result. BPF also could be confirmed by bronchos-
copy which should be performed as early as possible. We
hypothesized that RFA damaged lung tumors and caused
a tumoral necrosis hole. The hole resulted in the delayed
BPF and ended in empyema subsequently (Figure 2).
In early reports, few patients received thoractomy after
RFA and the data about pathological changes after RFA
were rare [17]. This patient, to our surprise, the posto-
perative pathology confirmed a multiple small foci diffe-
rentiated adenocarcinoma, partial bronchiolar - alveolar
carcinoma, 0.5 cm away around the hole at the sameFigure 3 The postoperative pathology confirmed partial
bronchiolar - alveolar carcinoma at the edge of hole(× 200).
Figure 4 Multiple small foci differentiated adenocarcinoma was
founded at the edge of hole after operation(×100).
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primary tumor 1 month after RFA. Does that suggest
that the primary tumor had satellite lesions, or it was
caused by the RFA treatment? Was it the reason of
tumor local progression? This finding would be greatly
helpful for understanding the pathological changes after
RFA and even for the treatment of RFA. Should a larger
ablation range be given around the tumor, or improved
RFA equipment be used for the ablation. It suggested
that radiofrequency electrodes might be placed in the
addition area more than 1 cm away surrounded the
tumor mass at least, repeated RFA and expand the range
of treatment might be helpful.
Conclusion
In conclusion, diagnose and treatments of the rare com-
plication of BPF were difficult. Surgery was a good option
for BPF especially when empyema occurred. Understan-
ding the limitations of radiofrequency may help to de-
crease the risks for complications, and the larger field
of ablation might be helpful for delaying the tumor
local progression.
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